In her new documentary, singer Celine Dion spotlights her battle with #StiffPersonSyndrome, a rare condition caused by an overactive immune system attacking the body's own cells. Our Chief Medical Officer, James Chung, shares more about this autoimmune disease with Daily Mail's Cassidy Morrison. He provides insights into the acute spasms Dion experiences, explaining how they can lead to muscle stiffness, reduced movement, excessive muscle tension, and painful spasms due to improper control over muscle contraction and relaxation. #AutoimmuneDisease #CARTcelltherapy #HopeForSPS https://lnkd.in/e-XsM9Hz
Kyverna Therapeutics
Biotechnology Research
Emeryville, California 13,748 followers
Harnessing the power of cell therapy in autoimmune disease.
About us
Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. Our lead product candidate, KYV-101 is advancing through clinical development across two broad areas of autoimmune disease: rheumatology and neurology, including Phase 2 trials for multiple sclerosis and myasthenia gravis, a Phase 1/2 trial for systemic sclerosis, and two ongoing multi-center, open-label Phase 1/2 trials in the United States and Germany for patients with lupus nephritis. Kyverna’s pipeline includes next-generation chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats with properties intended to be well suited for use in B cell-driven autoimmune diseases.
- Website
-
http://kyvernatx.com
External link for Kyverna Therapeutics
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Emeryville, California
- Type
- Public Company
- Founded
- 2018
- Specialties
- cell therapy, autoimmune, lupus, multiple sclerosis, systemic sclerosis, scleroderma, myasthenia gravis, and CAR T-cell
Locations
-
Primary
Get directions
5980 Horton St
Suite 550
Emeryville, California 94608, US
Employees at Kyverna Therapeutics
Updates
-
The number and quality of interactions at the European Academy of Neurology 2024 congress in Helsinki indicate the potential ground-breaking role that @cartcelltherapy could play in B cell-driven neurological #autoimmunedisease. A big Thank You to all who stopped by and spent time at our Kyverna Therapeutics booth. #KYV101
-
-
June 29th is #SclerodermaAwarenessDay! Let’s raise our voices for Scleroderma awareness. By sharing knowledge and supporting those affected, we can create a stronger, more informed community. Let’s empower resilience and hope. Learn more at www.kyvernatx.com. #cartcelltherapy #KYV101
-
-
We kicked off our annual #LFA ‘Walk to End Lupus Now’ fundraiser today! Special thanks to Sarah and Tracy for being part of the event at the Kyverna HQ in Emeryville, CA.
-
-
Kyverna Therapeutics reposted this
Kyverna Villagers just got an energy boost this summer - our 2024 interns support and learn about our efforts in bringing cell therapy to patients with autoimmune disease.
-
-
As Celine Dion opens up about battling #StiffPersonSyndrome, Carrie Robinette and Corwyn Wilkey share their journeys with ABC News' Diane Macedo about living with the condition and renewed hope in #cartcelltherapy to change the treatment paradigm. #CARTCelltherapy #StiffPersonSyndromeAwareness #CelineDion https://lnkd.in/ddVjHDix
-
-
Kyverna Therapeutics reposted this
We will be attending #EAN2024 in Helsinki, Finland, from June 29 to July 2. Visit us at booth E03 to discuss #cartcelltherapy in patients with #autoimmunedisease. #KYV-101 #multiplesclerosis #myastheniagravis
-
-
We will be attending #EAN2024 in Helsinki, Finland, from June 29 to July 2. Visit us at booth E03 to discuss #cartcelltherapy in patients with #autoimmunedisease. #KYV-101 #multiplesclerosis #myastheniagravis
-
-
We’re thrilled to host our first social media influencer meeting next week at our Emeryville, CA HQ. Anticipating a great deal of learning, brainstorming, and engaging in discussions to advance the understanding of a potential paradigm shift for patients with #autoimmunedisease. #impact2024
-
-
The participation and engagement at our satellite symposium at #EULAR2024 was truly amazing, and a clear example of how much interest the medical community is demonstrating in changing the current treatment paradigm for patients living with #autoimmunedisease. #cartcelltherapy #KYV-101
-